DRAP Guidelines on National Pharmacovigilance System: Indicators
The final article of the cycle provides additional details regarding specific indicators used in the context of a pharmacovigilance system.
The final article of the cycle provides additional details regarding specific indicators used in the context of a pharmacovigilance system.
The new article elaborates further on the existing types of surveillance, highlighting the key points associated thereto.
The article highlights the critical points associated with clinical practice inspections in Pakistan.
The new article describes in detail the relevant inspection process, highlighting the key points to be considered by the parties involved.
The new article addresses specific aspects related to GCP inspections, including, among other things, the ones associated with reporting, the checklist to be followed, and necessary documentation.
The new article describes the approach to be applied concerning reporting and record-keeping in the context of clinical investigations associated with medical devices intended to be marketed and used in Pakistan.
#WednesdayWebinar Join us for our upcoming webinar Global Regulatory Changes to Expect in 2025 January 22, 2025 at 10 AM ET
Register Now